StonvexLoading…
StonvexStonvexStonvexCore line items from DCBO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $242.69M | $216.93M | $180.84M | $142.91M |
Operating Income | $23.24M | $21.29M | $-3.71M | $4.18M |
Net Income | $37.51M | $26.74M | $2.84M | $7.02M |
EPS (Diluted) | $1.28 | $0.86 | $0.08 | $0.21 |
Total Assets | $206.65M | $190.71M | $158.38M | $283.67M |
Total Liabilities | $132.56M | $132.95M | $107.65M | $91.46M |
Cash & Equivalents | $74.04M | $92.54M | $71.95M | $216.29M |
Free Cash Flow OCF − CapEx | $27.19M | $28.00M | $15.33M | $1.21M |
Shares Outstanding | Not available | Not available | Not available | Not available |